Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
Status:
Completed
Trial end date:
2013-03-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of isavuconazole versus
voriconazole in the treatment of patients with invasive aspergillosis.